Strategies to Improve Antineoplastic Activity of Drugs in Cancer Progression

• Autore: Stefanachi Angela
• Pubblicazione: Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
• Descrizione fisica: 1 electronic resource (416 p.)
• Soggetto topico: Research & information: general; Biology, life sciences
• Soggetto non controllato: EGR-1; flavonoid; (E)-5-((4-oxo-4H-chromen-3-yl)methyleneamino)-1-phenyl-1H-pyrazole-4-carbonitrile; MDA-MB-231; MMP9; TNFα; pancreatic ductal adenocarcinoma; cyclodextrin inclusion complex; phase solubility studies; preformulation studies; biphenylnicotinamide derivatives; dual inhibitor; EGFR; VEGFR2; ligand-based pharmacophore; molecular docking; molecular dynamics; leukemias; doxorubicin; inflammation; drug delivery; tumor targeting; elastin-like polypeptide; cell penetrating peptide; matrix metalloproteinase; doxorubicin resistance; photosensitizer delivery system; PAMAM dendrimer; photodynamic therapy; cytotoxicity; phototoxicity; colorectal adenocarcinoma; dicarboximides; chemical synthesis; apoptosis; kinases; anticancer; gene profiling; SAR; biomarkers; colorectal cancer; early detection examination; liquid biopsy; personalized medicine; tumor treatment; exosomes; ctDNA; CTC; cytotoxic activity; pyrazole derivatives; MTT assay; ADMET analysis; single-crystal diffraction; FTIR spectroscopy; NMR spectroscopy thermogravimetric analysis; acute myelogenous leukemia; platelets; microparticles; γδ T cells; immunotherapy; tumor resistance; combination therapy; tumor microenvironment; immune checkpoint inhibitor; neuroblastoma; molecular iodine; cyclophosphamide; xenografts; metronomic therapy; tamoxifen; CYP2D6; MCF-7; Ishikawa cells; SERM; TNBC; uterotrophic; α-mangostin; poly(amidoamine) dendrimer; targeted drug delivery; biotin targeting; glioblastoma multiforme; squamous cell carcinoma; antiparasitic therapy; diclofenac; indomethacin; oleanolic acid derivative conjugates; NF-κB; Nrf2; MAPKs; PSN-1 cells; reactive oxygen species; glioblastoma; brain tumor; extracellular vesicles; pancreatic cancer; paclitaxel; clathrin; endocytosis; sulforaphane; nicotine; metalloproteinase-9; gastric cancer; cell invasion; Arylquin 1; colon cancer; tumor progression; azelastine; oxidative stress; autophagy; mitotic catastrophe; chronic myeloid leukemia; imatinib; tyrosine kinase; ketoconazole; P-glycoprotein; drug efflux transporter; non-small-cell lung cancer; cisplatin resistance; aldehyde dehydrogenase; isothiocyanates; disulfiram; epithelial to mesenchymal transition; aminopeptidase N; acetamidophenones; Schiff bases; semicarbazones; thiosemicarbazones; inhibition of proliferation
• Persona (resp. second.): StefanachiAngela
• Sommario/riassunto: The aim of this Special Issue is to collect reports regarding all the recent strategies, directed at the improvement of antineoplastic activity of drugs in cancer progression, engaging all the expertise needed for the development of new anticancer drugs: medicinal chemistry, pharmacology, molecular biology, and computational and drug delivery studies.
• Titolo autorizzato: Strategies to Improve Antineoplastic Activity of Drugs in Cancer Progression
• ISBN: 3-0365-5927-2
• Formato: Materiale a stampa
• Livello bibliografico: Monografia
• Lingua di pubblicazione: Inglese
• Record Nr.: 9910639990003321
• Lo trovi qui: Univ. Federico II